福瑞股份收盘上涨7.77%，滚动市盈率86.80倍，总市值86.11亿元

Group 1 - The core viewpoint of the article highlights the performance and valuation of Furuya Co., Ltd., which closed at 32.33 yuan, up 7.77%, with a rolling PE ratio of 86.80, marking a new low in 20 days, and a total market capitalization of 8.611 billion yuan [1] - The average PE ratio for the medical device industry is 48.90, with a median of 36.41, placing Furuya Co., Ltd. at the 102nd position in the industry ranking [1] - As of April 20, 2025, the number of shareholders for Furuya Co., Ltd. is 21,276, a decrease of 279 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Furuya Co., Ltd. specializes in the production and sales of drugs in the liver disease field, development and sales of diagnostic equipment, and related medical services, with its main product being the Compound Turtle Shell Soft Liver Tablets [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 330 million yuan, a year-on-year increase of 2.35%, and a net profit of 28.637 million yuan, a year-on-year decrease of 32.97%, with a gross profit margin of 76.76% [1]